Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin in Lupus Nephritis
NCT05704088Phase 4Completed
- Sponsor
- Mansoura University
- Start
- Oct 2022
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dapagliflozin in lupus nephritis (LN) (2 arms), sponsored by Mansoura University. Primary endpoints: Effect of dapagliflozin on renal function at 1 year, Effect of dapagliflozin on Bone Mineral Density at 1 year and 2 more. Started Oct 2022; status: completed.
02
Drugs
dapagliflozin
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT05704088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05704088.